426 related articles for article (PubMed ID: 25950115)
1. Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma.
Hou B; Ishinaga H; Midorikawa K; Shah SA; Nakamura S; Hiraku Y; Oikawa S; Murata M; Takeuchi K
Cancer Biol Ther; 2015; 16(7):1042-6. PubMed ID: 25950115
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.
Hsu CM; Lin PM; Wang YM; Chen ZJ; Lin SF; Yang MY
Tumour Biol; 2012 Dec; 33(6):1933-42. PubMed ID: 22811001
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.
Kimura S; Naganuma S; Susuki D; Hirono Y; Yamaguchi A; Fujieda S; Sano K; Itoh H
Oncol Rep; 2010 Jun; 23(6):1625-33. PubMed ID: 20428818
[TBL] [Abstract][Full Text] [Related]
5. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.
Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H
Radiat Oncol; 2013 Dec; 8():296. PubMed ID: 24373621
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers.
Hudcova K; Raudenska M; Gumulec J; Binkova H; Horakova Z; Kostrica R; Babula P; Adam V; Masarik M
Tumour Biol; 2016 Sep; 37(9):12627-12633. PubMed ID: 27440205
[TBL] [Abstract][Full Text] [Related]
7. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
10. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
11. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
12. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
Ren W; Qiang C; Gao L; Li SM; Zhang LM; Wang XL; Dong JW; Chen C; Liu CY; Zhi KQ
Biomarkers; 2014 Nov; 19(7):590-6. PubMed ID: 25174622
[TBL] [Abstract][Full Text] [Related]
16. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery.
Wang WT; Zhao YN; Yan JX; Weng MY; Wang Y; Chen YQ; Hong SJ
J Hematol Oncol; 2014 Jan; 7():6. PubMed ID: 24405714
[TBL] [Abstract][Full Text] [Related]
17. Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
Panvongsa W; Siripoon T; Worakitchanon W; Arsa L; Trachu N; Jinawath N; Ngamphaiboon N; Chairoungdua A
Cancer Sci; 2021 Oct; 112(10):4257-4269. PubMed ID: 34273216
[TBL] [Abstract][Full Text] [Related]
18. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Oncogenic Targets by
Okada R; Koshizuka K; Yamada Y; Moriya S; Kikkawa N; Kinoshita T; Hanazawa T; Seki N
Cells; 2019 Nov; 8(12):. PubMed ID: 31795200
[TBL] [Abstract][Full Text] [Related]
20. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
